The therapeutic potential of ischemic conditioning: an update (Q37892335)

24 August 2017

1 reference

title

The therapeutic potential of ischemic conditioning: an update (English)

1 reference

24 August 2017

1

Derek J Hausenloy

1 reference

24 August 2017

Derek M Yellon

2

1 reference

24 August 2017

language of work or name

English

0 references

publication date

21 June 2011

1 reference

Nature Reviews Cardiology

24 August 2017

1 reference

24 August 2017

8

1 reference

24 August 2017

619-629

1 reference

24 August 2017

11

1 reference

https://scigraph.springernature.com/pub.10.1038/nrcardio.2011.85

24 August 2017

0 references

cites work

Myocardial reperfusion: a double-edged sword?

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Myocardial reperfusion injury.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Signal transduction of ischemic preconditioning

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Preconditioning the Myocardium: From Cellular Physiology to Clinical Cardiology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Signaling pathways in ischemic preconditioning

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Postconditioning: old wine in a new bottle?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Cardioprotection: nitric oxide, protein kinases, and mitochondria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Signalling pathways in ischaemic postconditioning.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Remote ischaemic preconditioning: underlying mechanisms and clinical application.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

The second window of preconditioning (SWOP) where are we now?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Changes in ventricular fibrillation threshold during repeated short-term coronary occlusion and release

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Regional ischemic 'preconditioning' protects remote virgin myocardium from subsequent sustained coronary occlusion

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Myocardial protection by brief ischemia in noncardiac tissue

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Ischemic preconditioning at a distance: reduction of myocardial infarct size by partial reduction of blood supply combined with rapid stimulation of the gastrocnemius muscle in the rabbit

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Transient limb ischemia induces remote ischemic preconditioning in vivo.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Intermittent peripheral tissue ischemia during coronary ischemia reduces myocardial infarction through a KATP-dependent mechanism: first demonstration of remote ischemic perconditioning.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Remote ischaemic postconditioning protects the heart during acute myocardial infarction in pigs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

31 March 2020

Remote preconditioning

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

The neural and humoral pathways in remote limb ischemic preconditioning

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Postconditioning for protection of the infarcting heart

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Postconditioning the human heart

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Effect of postconditioning on infarct size in patients with ST elevation myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Long-term benefit of postconditioning

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Rationale and design of the POSTEMI (postconditioning in ST-elevation myocardial infarction) study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Design and methodologies of the POSTconditioning during coronary angioplasty in acute myocardial infarction (POST-AMI) trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Cardioprotective role of remote ischemic periconditioning in primary percutaneous coronary intervention: enhancement by opioid action

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Correlation of coronary artery bypass surgery-related myonecrosis with grafted vessel calibre: insights from cardiovascular magnetic resonance imaging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Association between CK-MB elevation after percutaneous or surgical revascularization and three-year mortality

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Short- and long-term prognostic value of postoperative cardiac troponin I concentration in patients undergoing coronary artery bypass grafting.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Cardiac troponin T for prediction of short- and long-term morbidity and mortality after elective open heart surgery.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Relationship between postoperative cardiac troponin I levels and outcome of cardiac surgery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

'Conditioning' the heart during surgery.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Coronary microembolization: from bedside to bench and back to bedside

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Preconditioning the human myocardium

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Ischaemic preconditioning reduces troponin T release in patients undergoing coronary artery bypass surgery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Ischaemic preconditioning during cardiac surgery: systematic review and meta-analysis of perioperative outcomes in randomised clinical trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Randomized controlled trial of the effects of remote ischemic preconditioning on children undergoing cardiac surgery: first clinical application in humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Does remote organ ischaemia trigger cardiac preconditioning during coronary artery surgery?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Remote ischemic preconditioning in human coronary artery bypass surgery: from promise to disappointment?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Postconditioning in cardiac surgery for tetralogy of Fallot.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Clinical benefit of cardiac ischemic postconditioning in corrections of tetralogy of Fallot

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Effect of ischemic postconditioning in adult valve replacement

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: results of the CK-MB and PCI study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Troponin Elevation After Percutaneous Coronary Intervention Directly Represents the Extent of Irreversible Myocardial Injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Peri-procedural myocardial injury during percutaneous coronary intervention: an important target for cardioprotection.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Effects of intermittent lower limb ischaemia on coronary blood flow and coronary resistance in pigs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Effects of remote ischemic preconditioning on the flow pattern of the left anterior descending coronary artery in normal subjects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Remote ischemic preconditioning stimulus does not reduce microvascular resistance or improve myocardial blood flow in patients undergoing elective percutaneous coronary intervention

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Increased C reactive protein and cardiac enzyme levels after coronary stent implantation. Is there protection by remote ischaemic preconditioning?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Cardiac Remote Ischemic Preconditioning in Coronary Stenting (CRISP Stent) Study: a prospective, randomized control trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Effect of cyclosporine on reperfusion injury in acute myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Effect of cyclosporine on left ventricular remodeling after reperfused myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Myocardial protection at a crossroads: the need for translation into clinical therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Cardiac protection during acute myocardial infarction: where do we stand in 2004?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Why do we still not have cardioprotective drugs?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Cardiac preconditioning for ischaemia: lost in translation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Remote ischaemic preconditioning reduces myocardial injury in patients undergoing cardiac surgery with cold-blood cardioplegia: a randomised controlled trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Effects of remote ischemic preconditioning on biochemical markers and neurologic outcomes in patients undergoing elective cervical decompression surgery: a prospective randomized controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Remote preconditioning improves maximal performance in highly trained athletes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Limb ischemic preconditioning reduces heart and lung injury after an open heart operation in infants

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Remote ischemic preconditioning reduces myocardial injury after coronary artery bypass surgery with crystalloid cardioplegic arrest.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Myocardial injury is decreased by late remote ischaemic preconditioning and aggravated by tramadol in patients undergoing cardiac surgery: a randomised controlled trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Brief repetitive balloon occlusions enhance reperfusion during percutaneous coronary intervention for acute myocardial infarction: a pilot study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Effect of postconditioning on coronary blood flow velocity and endothelial function and LV recovery after myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Concordant improvements in coronary flow reserve and ST-segment resolution during percutaneous coronary intervention for acute myocardial infarction: a benefit of postconditioning

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

A 60-s postconditioning protocol by percutaneous coronary intervention inhibits myocardial apoptosis in patients with acute myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Postconditioning the human heart in percutaneous coronary intervention

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Cardioprotective effects of ischemic postconditioning in patients treated with primary percutaneous coronary intervention, evaluated by magnetic resonance.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Long-term follow-up of patients undergoing postconditioning during ST-elevation myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Postconditioning attenuates myocardial injury by reducing nitro-oxidative stress in vivo in rats and in humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

A single dose of erythropoietin in ST-elevation myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

A Single Bolus of a Long-acting Erythropoietin Analogue Darbepoetin Alfa in Patients with Acute Myocardial Infarction: A Randomized Feasibility and Safety Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Single-dose intravenous administration of recombinant human erythropoietin is a promising treatment for patients with acute myocardial infarction - randomized controlled pilot trial of EPO/AMI-1 study -.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Erythropoietin prevention trial of coronary restenosis and cardiac remodeling after ST-elevated acute myocardial infarction (EPOC-AMI): a pilot, randomized, placebo-controlled study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Erythropoietin in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomized, double-blind trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Intravenous erythropoietin in patients with ST-segment elevation myocardial infarction: REVEAL: a randomized controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Intracoronary KAI-9803 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

High-dose erythropoietin in patients with acute myocardial infarction: A pilot, randomised, placebo-controlled study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

The effect of intravenous administration of erythropoietin on the infarct size in primary percutaneous coronary intervention

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.85

Remote Ischemic Preconditioning Reduces Myocardial and Renal Injury After Elective Abdominal Aortic Aneurysm Repair: A Randomized Controlled Trial

31 March 2020

1 reference

12 December 2020

Ventricular premature beat—driven intermittent restoration of coronary blood flow reduces the incidence of reperfusion-induced ventricular fibrillation in a cat model of regional ischemia

1 reference

12 December 2020

Attenuation of tumor necrosis factor-alpha elevation and improved heart function by postconditioning for 60 seconds in patients with acute myocardial infarction

1 reference

12 December 2020

Reduction in myocardial infarct size by postconditioning in patients after percutaneous coronary intervention.

1 reference

12 December 2020

The effect of remote ischaemic preconditioning on myocardial injury in patients undergoing off-pump coronary artery bypass graft surgery

1 reference

12 December 2020

Induced remote ischemic pre-conditioning on ischemia-reperfusion injury in patients undergoing coronary artery bypass

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRCARDIO.2011.85

1 reference

Dimensions Publication ID

24 August 2017

1030217402

0 references

Fatcat ID

release_gwu34qvztbanhc33qpvdvh5pgy

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/gwu34qvztbanhc33qpvdvh5pgy

24 November 2022

mapped directly with Wikidata item

1 reference